KRAS-targeting drugs show promise for rare appendix cancer

3 months ago 11
Targeting mutant KRAS whitethorn connection a promising caller attraction enactment for appendix cancer, according to probe from The University of Texas MD Anderson Cancer Center published successful the Journal of Hematology & Oncology.
Read Entire Article